ETNB Stock 89bio (ETNB, $8.68) was a top loser this quarter, falling -34.79%

A.I.dvisor
at Tickeron.com
06/12/24
Loading...
ETNB - 89bio

Loading...

Price: $8.68
Daily change: +$0.21 (+2.48%)
Daily volume: 1.2M
3-month price change: -$4.63 (-34.79%)
Capitalization: $854M
Industry: Biotechnology
89bio (ETNB, $8.68) was a top loser over the last three months, falling -3 to $8.68 per share. A.I.dvisor analyzed 894 stocks in the Biotechnology Industry for the 3-month period ending June 11, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
142 Sansome Street
Phone
+1 415 432-9270
Employees
70
Web
https://www.89bio.com